Identifying a potential role of immune cells in gadolinium deposition within the brain

Abstract Background Gadolinium (Gd) deposition in the brain was observed in patients with history of gadolinium-based contrast agent (GBCA) administration. However, the exact mechanism behind this deposition remains unclear, especially given that an intact blood-brain barrier (BBB) is considered imp...

Full description

Saved in:
Bibliographic Details
Main Authors: Dixy Parakkattel, Nico Ruprecht, Peter Broekmann, Sarah Guimbal, Chiara Stüdle, Sasha Soldati, Johannes T. Heverhagen, Britta Engelhardt, Hendrik von Tengg-Kobligk
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Fluids and Barriers of the CNS
Subjects:
Online Access:https://doi.org/10.1186/s12987-025-00674-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225969625202688
author Dixy Parakkattel
Nico Ruprecht
Peter Broekmann
Sarah Guimbal
Chiara Stüdle
Sasha Soldati
Johannes T. Heverhagen
Britta Engelhardt
Hendrik von Tengg-Kobligk
author_facet Dixy Parakkattel
Nico Ruprecht
Peter Broekmann
Sarah Guimbal
Chiara Stüdle
Sasha Soldati
Johannes T. Heverhagen
Britta Engelhardt
Hendrik von Tengg-Kobligk
author_sort Dixy Parakkattel
collection DOAJ
description Abstract Background Gadolinium (Gd) deposition in the brain was observed in patients with history of gadolinium-based contrast agent (GBCA) administration. However, the exact mechanism behind this deposition remains unclear, especially given that an intact blood-brain barrier (BBB) is considered impermeable to GBCA. In this study, we propose that immune cells might play a role in facilitating GBCA entry into the brain despite an intact BBB. Methods Gadoterate meglumine, gadoteridol, gadobutrol and gadodiamide were investigated as GBCAs. Immune cells from human donor buffy coats were isolated, incubated with the GBCA and used in the experiments. Gd associated with the immune cells were measured using single-cell inductively coupled mass spectrometry (SC-ICP-MS). Flow cytometry analysis was performed to characterise the adhesion molecule expression profile on the immune cells and binding assay was employed to check the binding of Gd treated immune cells with endothelial ligands in static conditions. An in vitro model of the human BBB that prevents free diffusion of GBCA across was further used to observe immune cell behaviour at the BBB under physiological flow, in vitro. Results Our findings confirm that various immune cells, including CD4+ T cells, CD8+ T cells, monocytes, NK cells and B cells are capable of taking up the different GBCAs. Furthermore, we demonstrate that GBCA loading does not impair immune cell interaction with the endothelial ligands required for successful extravasation across the BBB under static conditions. Most importantly, we show that T cells and monocytes, loaded with the different contrast agents, extravasated across an in vitro BBB model under physiological flow conditions in a comparable manner to non GBCA loaded cells. Conclusions Taken together, our in vitro observations show that immune cells can transport GBCA across the BBB and could lead to permanent deposition of Gd in the brain.
format Article
id doaj-art-24de5419aa5147edaa799c204ac7d582
institution Kabale University
issn 2045-8118
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Fluids and Barriers of the CNS
spelling doaj-art-24de5419aa5147edaa799c204ac7d5822025-08-24T11:46:28ZengBMCFluids and Barriers of the CNS2045-81182025-07-0122111610.1186/s12987-025-00674-5Identifying a potential role of immune cells in gadolinium deposition within the brainDixy Parakkattel0Nico Ruprecht1Peter Broekmann2Sarah Guimbal3Chiara Stüdle4Sasha Soldati5Johannes T. Heverhagen6Britta Engelhardt7Hendrik von Tengg-Kobligk8Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of BernDepartment of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of BernDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of BernTheodor Kocher Institute, University of BernTheodor Kocher Institute, University of BernTheodor Kocher Institute, University of BernDepartment of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of BernTheodor Kocher Institute, University of BernDepartment of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of BernAbstract Background Gadolinium (Gd) deposition in the brain was observed in patients with history of gadolinium-based contrast agent (GBCA) administration. However, the exact mechanism behind this deposition remains unclear, especially given that an intact blood-brain barrier (BBB) is considered impermeable to GBCA. In this study, we propose that immune cells might play a role in facilitating GBCA entry into the brain despite an intact BBB. Methods Gadoterate meglumine, gadoteridol, gadobutrol and gadodiamide were investigated as GBCAs. Immune cells from human donor buffy coats were isolated, incubated with the GBCA and used in the experiments. Gd associated with the immune cells were measured using single-cell inductively coupled mass spectrometry (SC-ICP-MS). Flow cytometry analysis was performed to characterise the adhesion molecule expression profile on the immune cells and binding assay was employed to check the binding of Gd treated immune cells with endothelial ligands in static conditions. An in vitro model of the human BBB that prevents free diffusion of GBCA across was further used to observe immune cell behaviour at the BBB under physiological flow, in vitro. Results Our findings confirm that various immune cells, including CD4+ T cells, CD8+ T cells, monocytes, NK cells and B cells are capable of taking up the different GBCAs. Furthermore, we demonstrate that GBCA loading does not impair immune cell interaction with the endothelial ligands required for successful extravasation across the BBB under static conditions. Most importantly, we show that T cells and monocytes, loaded with the different contrast agents, extravasated across an in vitro BBB model under physiological flow conditions in a comparable manner to non GBCA loaded cells. Conclusions Taken together, our in vitro observations show that immune cells can transport GBCA across the BBB and could lead to permanent deposition of Gd in the brain.https://doi.org/10.1186/s12987-025-00674-5Gadolinium-based contrast agentsImmune cell migrationBlood-brain barrier
spellingShingle Dixy Parakkattel
Nico Ruprecht
Peter Broekmann
Sarah Guimbal
Chiara Stüdle
Sasha Soldati
Johannes T. Heverhagen
Britta Engelhardt
Hendrik von Tengg-Kobligk
Identifying a potential role of immune cells in gadolinium deposition within the brain
Fluids and Barriers of the CNS
Gadolinium-based contrast agents
Immune cell migration
Blood-brain barrier
title Identifying a potential role of immune cells in gadolinium deposition within the brain
title_full Identifying a potential role of immune cells in gadolinium deposition within the brain
title_fullStr Identifying a potential role of immune cells in gadolinium deposition within the brain
title_full_unstemmed Identifying a potential role of immune cells in gadolinium deposition within the brain
title_short Identifying a potential role of immune cells in gadolinium deposition within the brain
title_sort identifying a potential role of immune cells in gadolinium deposition within the brain
topic Gadolinium-based contrast agents
Immune cell migration
Blood-brain barrier
url https://doi.org/10.1186/s12987-025-00674-5
work_keys_str_mv AT dixyparakkattel identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT nicoruprecht identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT peterbroekmann identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT sarahguimbal identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT chiarastudle identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT sashasoldati identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT johannestheverhagen identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT brittaengelhardt identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain
AT hendrikvontenggkobligk identifyingapotentialroleofimmunecellsingadoliniumdepositionwithinthebrain